ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EYEN Eyenovia Inc

0.5899
0.0473 (8.72%)
After Hours
Last Updated: 18:55:47
Delayed by 15 minutes

Period:

Draw Mode:

Volume 769,439
Bid Price 0.5643
Ask Price 0.59
News -
Day High 0.5989

Low
0.501

52 Week Range

High
5.85

Day Low 0.5383
Company Name Stock Ticker Symbol Market Type
Eyenovia Inc EYEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0473 8.72% 0.5899 18:55:47
Open Price Low Price High Price Close Price Prev Close
0.555 0.5383 0.5989 0.5835 0.5426
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,433 769,439 $ 0.5550704 $ 427,093 - 0.501 - 5.85
Last Trade Time Type Quantity Stock Price Currency
18:55:47 formt 250 $ 0.5899 USD

Eyenovia Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
25.59M 44.12M - 4k -27.26M -0.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Eyenovia News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No EYEN Message Board. Create One! See More Posts on EYEN Message Board See More Message Board Posts

Historical EYEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.5520.59890.510.5424352943,1690.03796.87%
1 Month1.011.020.5010.67559091,425,277-0.4201-41.59%
3 Months1.942.570.5011.311,238,096-1.35-69.59%
6 Months1.222.570.5011.39788,566-0.6301-51.65%
1 Year4.875.850.5011.89587,982-4.28-87.89%
3 Years5.306.630.5012.50339,132-4.71-88.87%
5 Years6.317.720.5013.20302,711-5.72-90.65%

Eyenovia Description

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

Your Recent History

Delayed Upgrade Clock